The decision between targeted and whole-genome sequencing approaches represents a critical fork in the road for many genomics researchers. While whole genome sequencing (WGS) offers comprehensive coverage of an organism’s DNA, specific scenarios exist where targeted amplification and sequencing of select regions proves more advantageous. This article examines the key situations where researchers should opt for PCR-based targeted approaches rather than whole-genome methods.
Focus on known targets
When your research questions centre on specific genes or genomic regions, sequencing the entire genome generates excessive data that goes unused. Consider a clinical investigation of known cancer hotspot mutations or antibiotic resistance genes – in these cases, focusing sequencing power exclusively on relevant regions delivers the necessary information without wasted resources. The targeted approach eliminates the “needle in a haystack” problem for projects investigating well-characterised genes or variants. Instead of sifting through billions of bases to find regions of interest, you directly generate data from precisely the genetic territories that answer your research question. This focused approach translates to simpler data analysis workflows and more straightforward interpretation of results.
Low-input DNA challenges
Samples with limited DNA quantity present particular challenges for whole-genome approaches, which typically require micrograms of high-quality DNA. Archaeological specimens, non-invasive samples, single-cell studies, and many clinical specimens often yield nanogram or even picogram quantities of DNA, which is insufficient for comprehensive sequencing without problematic amplification steps. Amplicon sequencing thrives in these low-input scenarios. The PCR amplification step effectively enriches specific regions from minimal starting material, making genetic analysis possible from samples incompatible with whole-genome methods. This capability unlocks research possibilities for precious specimens, rare samples, and materials where additional collection isn’t feasible.
The targeted approach also accommodates samples with mixed-quality DNA, as the shorter amplicons require less template integrity than the longer fragments needed for optimal whole-genome library preparation. This flexibility proves invaluable when working with archived samples, formalin-fixed tissues, or environmentally challenged specimens.
Time-sensitive investigations
- Clinical diagnostic applications where treatment decisions depend on rapid genetic results
- Infectious disease outbreaks requiring the quick identification of pathogen strains
- Food safety testing where contamination sources must be rapidly identified
- Forensic applications with urgent timeline requirements
- Conservation efforts responding to imminent threats to endangered populations
In these time-critical scenarios, the streamlined workflow of targeted approaches delivers actionable genetic information days or sometimes weeks faster than whole-genome methods. From sample preparation through sequencing to data analysis, each step in the targeted workflow completes more rapidly, enabling faster decision-making when time matters.
Rare variant detection needs
Identifying low-frequency variants presents significant challenges with standard-depth whole-genome sequencing. The targeted approach offers a critical advantage for applications seeking minor genetic components within heterogeneous samples: dramatically higher read depth for regions of interest.
- Cancer studies tracking subclonal mutations present in small percentages of cells
- Viral evolution studies monitoring emerging variants within mixed populations
- Microbiome analyses identifying rare but important community members
- Soil or water environmental DNA studies detecting uncommon species
- Mosaic disorder investigations where variants exist in a subset of tissues
By concentrating sequencing capacity on specific regions rather than spreading it across the entire genome, the targeted approach achieves the depth necessary to detect variants at 1% frequency or lower reliably. This sensitivity enables detection of emerging resistance mutations, rare species in mixed communities, and early genetic changes that might otherwise remain invisible.
The choice between sequencing approaches should always align with research objectives, sample realities, and practical constraints.
